AcouSort AB (publ) (FRA:4SA)

Germany · Delayed Price · Currency is EUR

0.180

-0.007 (-3.74%)

Last updated: Dec 5, 2025, 8:03 AM CET

-79.45% (1Y)

Market Cap	5.23M
Revenue (ttm)	976.87K
Net Income (ttm)	-1.12M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.180
Previous Close	0.187
Day's Range	0.180 - 0.180
52-Week Range	0.153 - 1.085
Beta	n/a
RSI	51.47
Earnings Date	Nov 26, 2025

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances

Founded 2010

Employees 16

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 4SA

Full Company Profile

Financial Performance

In 2024, AcouSort AB's revenue was 10.03 million, a decrease of -4.94% compared to the previous year's 10.55 million. Losses were -15.08 million, -11.77% less than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.